The Role of Tyrosine Kinase Inhibitors in Unresectable Hepatocellular Carcinoma - Episode 8
Medical experts discuss the selection of second-line treatments for patients who experience disease progression while on first-line therapy, highlighting the potential for deterioration in performance status and liver function.